FDA recall D-0507-2024

American Regent, Inc. · Class II · drug

Product

Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01

Reason for recall

Subpotent product in addition to having out-of-specification results for impurities.

Distribution

USA Nationwide

Key facts

Status
Terminated
Initiation date
2024-05-13
Report date
2024-05-29
Termination date
2025-12-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
New Albany, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0507-2024